Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherLetters to the Editor

Re: Fischman and Thrall Editorial, “Who Should Read … PET Studies”

Ted Yaeger
Journal of Nuclear Medicine November 2004, 45 (11) 1975;
Ted Yaeger
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

TO THE EDITOR:I had to laugh at the mental image conjured by these ivory tower academics who live in the heady world of “integrated subspecialty” everything (1).

I am very blessed to have trained in the Department of Radiation Oncology and Nuclear Medicine at Hahnemann University with Luther Brady, MD. Dr. Brady had the vision to see an integrated world of diagnostic studies helping oncologists to form a proper assessment of the patient. He led the research seeking, then applying, innovative diagnostic and treatment techniques. He required his residents to appreciate the same.

For nearly 20 years, I have been in a large community-based oncology practice. My training and continuous education are what have allowed me to realize the potential that modern radiology gives the clinician. One cannot underemphasize the importance of understanding the studies that are ordered. As such, it requires an oncology team approach to apply the interpretation of radiology studies and put them into the clinical setting. That team isn’t just radiologists but surgeons, medical oncologists, and radiation oncologists working in unison. I count myself lucky to work with such a team that includes excellent and dedicated radiologists. Like the blind men describing an elephant, all team members have useful perspectives and every experienced clinician has seen radiology misinterpretations when studies are done in a vacuum. Bringing diagnostic tools into the clinic is our job.

Over decades, radiation oncologists (formerly therapists) have been independently coordinating and interpreting diagnostic images, including nuclear scans. Presently, CT/intensity-modulated radiotherapy simulation for treatment planning demands some interpretation autonomy. Also, we are comparing sonograms to CT scans for prostate brachytherapy planning. The list goes on, yet Fischman and Thrall mention the treating clinician only in passing. I can only assume the “turf” question that causes them to designate radiology as the arbiter of diagnostic studies focuses on reimbursement issues. Outside of academia, the turf is changing.

Finally, to answer the question that titles the editorial of Fischman and Thrall, I humbly propose: Every physician involved in the patient’s care. Put reimbursement issues aside and there is no turf, just responsible patient care.

REFERENCES

  1. ↵
    Fischman AJ, Thrall JH. Who should read and interpret 18F-FDG PET studies? J Nucl Med.2003;44:1197–1199.
    OpenUrlFREE Full Text
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 45 (11)
Journal of Nuclear Medicine
Vol. 45, Issue 11
November 1, 2004
  • Table of Contents
  • About the Cover
  • Index by author
Print
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Re: Fischman and Thrall Editorial, “Who Should Read … PET Studies”
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Re: Fischman and Thrall Editorial, “Who Should Read … PET Studies”
Ted Yaeger
Journal of Nuclear Medicine Nov 2004, 45 (11) 1975;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Re: Fischman and Thrall Editorial, “Who Should Read … PET Studies”
Ted Yaeger
Journal of Nuclear Medicine Nov 2004, 45 (11) 1975;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • REFERENCES
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Business Model Beats Science and Logic: Dosimetry and Paucity of Its Use
  • Determining PSMA-617 Mass and Molar Activity in Pluvicto Doses
  • The Value of Functional PET in Quantifying Neurotransmitter Dynamics
Show more Letters to the Editor

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire